Search Page

1

Adenosine receptors as drug targets--what are the challenges?

Chen JF, Eltzschig HK, Fredholm BB. Chen JF, et al. Among authors: Fredholm BB. Nat Rev Drug Discov. 2013 Apr;12(4):265-86. doi: 10.1038/nrd3955. Nat Rev Drug Discov. 2013. PMID: 23535933 Free PMC article. Review.

Cite

Share

2

Adenosine and Sleep.

Lazarus M, Chen JF, Huang ZL, Urade Y, Fredholm BB. Lazarus M, et al. Among authors: Fredholm BB. Handb Exp Pharmacol. 2019;253:359-381. doi: 10.1007/164_2017_36. Handb Exp Pharmacol. 2019. PMID: 28646346 Review.

Cite

Share

3

Pharmacological targeting of adenosine receptor signaling.

Peleli M, Fredholm BB, Sobrevia L, Carlström M. Peleli M, et al. Among authors: Fredholm BB. Mol Aspects Med. 2017 Jun;55:4-8. doi: 10.1016/j.mam.2016.12.002. Epub 2017 Jan 12. Mol Aspects Med. 2017. PMID: 28088486 Review.

Cite

Share

4

Low, but not high, dose caffeine is a readily available probe for adenosine actions.

Fredholm BB, Yang J, Wang Y. Fredholm BB, et al. Mol Aspects Med. 2017 Jun;55:20-25. doi: 10.1016/j.mam.2016.11.011. Epub 2016 Nov 30. Mol Aspects Med. 2017. PMID: 27915051 Review.

Cite

Share

5

Notes on the history of caffeine use.

Fredholm BB. Fredholm BB. Handb Exp Pharmacol. 2011;(200):1-9. doi: 10.1007/978-3-642-13443-2_1. Handb Exp Pharmacol. 2011. PMID: 20859791

Cite

Share

6

International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Fredholm BB, IJzerman AP, Jacobson KA, Linden J, Müller CE. Fredholm BB, et al. Pharmacol Rev. 2011 Mar;63(1):1-34. doi: 10.1124/pr.110.003285. Epub 2011 Feb 8. Pharmacol Rev. 2011. PMID: 21303899 Free PMC article. Review.

Cite

Share

7

Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.

Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE. Fredholm BB, et al. Pharmacol Rev. 1999 Mar;51(1):83-133. Pharmacol Rev. 1999. PMID: 10049999 Review. No abstract available.

Cite

Share

8

Adenosine - from molecular mechanisms to pathophysiology.

Sobrevia L, Fredholm BB. Sobrevia L, et al. Among authors: Fredholm BB. Mol Aspects Med. 2017 Jun;55:1-3. doi: 10.1016/j.mam.2017.06.003. Epub 2017 Jun 17. Mol Aspects Med. 2017. PMID: 28624328 No abstract available.

Cite

Share

9

Adenosine--a physiological or pathophysiological agent?

Fredholm BB. Fredholm BB. J Mol Med (Berl). 2014 Mar;92(3):201-6. doi: 10.1007/s00109-013-1101-6. Epub 2013 Dec 22. J Mol Med (Berl). 2014. PMID: 24362516 Review.

Cite

Share

10

The birth and postnatal development of purinergic signalling.

Burnstock G, Fredholm BB, North RA, Verkhratsky A. Burnstock G, et al. Among authors: Fredholm BB. Acta Physiol (Oxf). 2010 Jun;199(2):93-147. doi: 10.1111/j.1748-1716.2010.02114.x. Epub 2010 Mar 24. Acta Physiol (Oxf). 2010. PMID: 20345419 Review.

Cite

Share